Development and validation of a scale to measure symptoms of chronic graft-versus-host disease

Biology of Blood and Marrow Transplantation

Volumn 8, Issue 8, 2002, Pages 444-452

  Lee, Stephanie J ^a   Cook, E Francis ^a   Soiffer, Robert ^a   Antin, Joseph H ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Chronic graft versus host disease; Outcomes research; Quality of life; Stem cell transplantation

Indexed keywords

CYCLOSPORIN; STEROID; TACROLIMUS;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; FUNCTIONAL ASSESSMENT; GRAFT VERSUS HOST REACTION; HEALTH STATUS; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; OUTCOMES RESEARCH; PROSPECTIVE STUDY; QUALITY OF LIFE; RATING SCALE; RECIPIENT; RELIABILITY; SURVIVAL RATE; SYMPTOMATOLOGY; VALIDATION PROCESS; WELLBEING; ALLOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; CROSS-SECTIONAL STUDY; HOSPITALIZATION; INFORMATION PROCESSING; KARNOFSKY PERFORMANCE STATUS; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; PSYCHOLOGICAL ASPECT; VALIDATION STUDY;

ADULT; BONE MARROW TRANSPLANTATION; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; DATA COLLECTION; FEMALE; GRAFT VS HOST DISEASE; HUMANS; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TRANSPLANTATION, HOMOLOGOUS;

EID: 0036374452     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1053/bbmt.2002.v8.pm12234170     Document Type: Article

References (31)

1. Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease
2. Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: Prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation
3. Predictors of death from chronic graft-versus-host disease after bone marrow transplantation
4. Value of day 100 screening studies for predicting the development of chronic graft-versus-host disease after allogeneic bone marrow transplantation
5. Health and functional status of long-term survivors of bone marrow transplantation: EBMT Working Party on Late Effects and EULEP Study Group on Late Effects: European Group for Blood and Marrow Transplantation
6. Long-term survival and late deaths after allogeneic bone marrow transplantation: Late Effects Working Committee of the International Bone Marrow Transplant Registry
7. Quality of life following bone marrow transplantation: A comparison of patient reports with population norms
8. Recovery after allogeneic marrow transplantation: Prospective study of predictors of long-term physical and psychosocial functioning
9. High incidence of chronic GVHD after primary allogeneic peripheral blood stem cell transplantation in patients with hematologic malignancies
10. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease
11. High incidence of chronic graft versus host disease after allogeneic peripheral blood progenitor cell transplantation: The Spanish Group of Allo-PBPCT
12. Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors: A case-control study: Spanish Group of Allo-PBT
13. A trend towards an increased incidence of chronic graft-versus-host disease following allogeneic peripheral blood progenitor cell transplantation: A case controlled study
14. A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center: A focus on the incidence of graft-vs.-host disease and relapse
15. Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: A report from the Societe Francaise de Greffe de Moelle
16. Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: A meta-analysis
17. Transplant-lite: Induction of graft-versus-malignancy using fludarabine-based non-ablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies
18. Melphalan and purine analog-containing preparative regimens: Reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation
19. Hematopoietic cell transplantation in older patients with hematologic malignancies: Replacing high-dose cytotoxic therapy with graft-versus-tumor effects
20. Severity of chronic graft-vs.-host disease: Association with treatment-related mortality and relapse
21. SF-36 Health Survey: A Manual and Interpretation Guide
22. SF-36 Physical and Mental Health Summary Scales: A User's Manual
23. Quality of life measurement in bone marrow transplantation: Development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale
24. Chronic graft-versus-host syndrome in man: A long-term clinicopathologic study of 20 Seattle patients
25. Measurement of health status: Ascertaining the minimal clinically important difference
26. Interpretation of quality of life changes
27. Determining a minimal important change in a disease-specific quality of life questionnaire
28. Interpreting the significance of changes in health-related quality-of-life scores
29. Capturing the patient's view of change as a clinical outcome measure
30. Estimating leukemia-free survival after allografting for chronic myeloid leukemia: A new method that takes into account patients who relapse and are restored to complete remission
31. Asking the obvious questions regarding patient burden